Pollak: 2026

Mathew Gorman, Nawaid Usmani, Michael N. Pollak, Sunita Ghosh, Arun Elangovan, Julian Kim, John Thoms, Myriam Bouchard, Michael Peacock, Ye Wang, Neil E. Fleshner, Holly Campbell, Eric Vigneault, Francois Vincent, Alan So, Fabio L. Cury, Harvey C. Quon, Ryan G. Carlson Jr., Carole Lambert, Laurence Klotz, Kim Chi, Michael Brundage, Kerry S. Courneya, Bernhard J. Eigl. Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer. Endocr Oncol. 2026 Jul 1;6(1):e250114.

Lysanne Desharnais, Anikka Swaby, Meriem Messaoudene, Samuel Doré, Miranda W. Yu, Benoit Fiset, Valérie Breton, Mayra Ponce, Yongjia Hu, Liam Wilson, Mark Sorin, Ye Wang, Ken Dewar, Michael Pollak, Arielle Elkrief, Bertrand Routy, Logan A. Walsh, Daniela F. Quail. Diet-microbiome synergy underlies obesity-associated immunotherapy efficacy. Nature. 2026 Jul 8. Online ahead of print.

Vernon A. Burk, Michael N. Pollak, Corinne E. Joshu, Anna Prizment, Elizabeth A. Platz. Plasma insulin-like growth Factor-Binding protein 7 predicts 20-Year Cancer-Specific and overall survival in ARIC. J Natl Cancer Inst. 2026 Jul 15:djag238. Online ahead of print.

Andrew G Renehan, Michael N Pollak. Appetite, Obesity, Metabolism, and Malignancy: Do Incretin-Mimetic Drugs Reduce Cancer Risk? Cancer Prev Res (Phila). 2026 Apr 1;19(4):187-196.

Zhi Li, Chengzhe Tao, Ziyi Zhou, Michael N Pollak, Edward L Giovannucci, Mingyang Song. Circulating levels of insulin-like growth factor binding protein 7 are associated with risks of chronic diseases and death. NPJ Aging. 2026 May 9. Online ahead of print.

*Natasha J Stonebanks Cuillerier, Hamda Almarzooqi, *Victor Villareal-Corpuz, Sarah Sabboobeh, Ipshita Prakash, Mark Basik, Jean Francois Boileau, Karyne Martel, Sarkis Meterissian, Michael Pollak, Stephanie M Wong. Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen. Ann Surg Oncol. 2026 May;33(5):4510-4517.

Karine Alcala, Daniela Mariosa, Sara Jacobson, Claudia Coscia-Requena, Niki Dimou, Oskar Franklin, Richard M Martin, George Davey Smith, Marc J Gunter, Paul Brennan, Michael Pollak, Ryan Langdon, Mattias Johansson. Systematic assessment of obesity-related risk factors in renal cancer etiology: A longitudinal risk and mendelian randomization analysis. PLoS Med. 2026 Feb 10;23(2):e1004906.

William A Pace, Adam Olshen, Ye Wang, Stacey A Kenfield, Erin L Van Blarigan, Rebecca E Graff, Janet Cowan, Lufan Wang, Imelda Tenggara, Karen Lopez, Katriel Encabo, Lee W Jones, Neil Panchal, Matthew R Cooperberg, Peter R Carroll, Anthony Luke, Michael Pollak, June M Chan. Inflammation and insulin profiles in men assigned to exercise vs. usual care for prostate cancer: results from the active surveillance exercise (ASX) randomized controlled trial. Cancer Causes Control. 2026 Jan 17;37(2):22.

Stacey A Kenfield, Nicolas H Hart, Kerry S Courneya, Rosemary Greenwood, June M Chan, Jennette Sison, Li Zhang, Sarah Rudman, Leah Ung, Moritz Schumann, Erin L Van Blarigan, Sam McKeown, Charles J Ryan, James Catto, Daniel A Galvão, Robert U Newton, Fred Saad; INTERVAL-GAP4 Site Investigators and INTERVAL-GAP4 Steering and Management Committees (Robert U Newton, Fred Saad, Arash Asher, Freerk Baumann, Wilhelm Bloch, Hans Bussmann, James Catto, June M Chan, Jeff Coombes, Kerry S Courneya, Stephen P Finn, Daniel A Galvão, Rosemary Greenwood, Emer Guinan, Nicolas H Hart, Alan Hayes, Daniel C Hughes, Suneil Jain, Stacey A Kenfield, Elizabeth Kessler, Ralph Manders, Lorelei A Mucci, Colleen Nelson, Stephen R Plymate, Michael Pollak, Stephan Praet, Gillian Prue, Sarah Rudman, Charles J Ryan, Moritz Schumann, Jennette Sison, Tina Skinner, Erin L Van Blarigan, Mieke Van Hemelrijck, Kerri Winters-Stone, Harriet Wylie). Feasibility and Implementation of INTERVAL-GAP4: A Global Randomised Controlled Trial of Intense Hybrid-supervised/Self-managed Versus Self-directed Exercise for Metastatic Prostate Cancer. Eur Urol Open Sci. 2026 Jan 7:84:29-39.